Biorez Closes Financing, Prepares for Human Testing

Biorez closed a US $1.5MM C-1 financing led by Connecticut Innovations, with participation from LaunchCapital, The Vertical Group and New York Angels. The company is on track for 2019 launch of a human clinical study with a novel implant for anterior cruciate ligament (ACL) reconstruction, following positive results from animal testing.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us